10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001683168-23-003201`
Period End Date	20230331
Filing Date	20230511
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	xenetic_i10q-033123_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 28 Cash Flow Statement 28 Stockholders Equity 13

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$11.99M	USD	Point-in-time
Cash	`Cash`	$13.10M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$876.54K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$556.09K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.65M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.87M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.07M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$844.43K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.19M	shares	Point-in-time
Total assets	`Assets`	$13.72M	USD	Point-in-time
Total assets	`Assets`	$14.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.19M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.17M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.17M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$287.36K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$259.18K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$597.18K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$785.80K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$856.37K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$856.37K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 15,193,587 shares issued as of March 31, 2023 and December 31, 2022; 15,166,596 shares outstanding as of March 31, 2023 and December 31, 2022	`CommonStockValue`	$15.19K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 15,193,587 shares issued as of March 31, 2023 and December 31, 2022; 15,166,596 shares outstanding as of March 31, 2023 and December 31, 2022	`CommonStockValue`	$15.19K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$207.76M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$207.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-189.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-189.10M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockCommonValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.92M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.65M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.72M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.72M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.06	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$605.84K	USD	1 Quarter
Royalty revenue	`RoyaltyIncomeNonoperating`	$388.99K	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.06	USD	1 Quarter
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.44M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	15.17M	shares	1 Quarter
Total revenue	`Revenues`	$605.84K	USD	1 Quarter
Total revenue	`Revenues`	$388.99K	USD	1 Quarter
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.17M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.44M	shares	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$595.28K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.10M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$925.74K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$907.31K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$2.01M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.52M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-915.17K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.62M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$199.00	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$4.52K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$54.10K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$25.91K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$26.10K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$58.62K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-856.55K	USD	1 Quarter

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-856.55K	USD	1 Quarter
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	-	USD	1 Quarter
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$9.47K	USD	1 Quarter
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$119.59K	USD	1 Quarter
Share-based expense	`EmployeeBenefitsAndShareBasedCompensation`	$68.85K	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$320.44K	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInAccountsAndOtherReceivables`	$262.44K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.87K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-222.50K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-357.83K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-216.79K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.10M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.09M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.09M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.10M	USD	1 Quarter
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.99M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.16M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.99M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.10M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.16M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.24M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$2.00	USD	1 Quarter

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$12.86M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.92M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$119.59K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$68.85K	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-856.55K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$12.86M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.92M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$13.65M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.